HCID 17985192, compound → HCID 53708183, compound
Reaction equation
[NH2:1][C:2]1[C:11]2[C:6](=[CH:7][C:8]([CH2:12][N:13]3[CH2:18][CH2:17][NH:16][CH:15]([CH3:19])[C:14]3=[O:20])=[CH:9][CH:10]=2)[N:5]=[CH:4][N:3]=1.[Cl:21][C:22]1[CH:23]=[C:24](/[CH:27]=[CH:28]/[C:29](O)=[O:30])[S:25][CH:26]=1>>[NH2:1][C:2]1[C:11]2[C:6](=[CH:7][C:8]([CH2:12][N:13]3[CH2:18][CH2:17][N:16]([C:29](=[O:30])[CH:28]=[CH:27][C:24]4[S:25][CH:26]=[C:22]([Cl:21])[CH:23]=4)[C@@H:15]([CH3:19])[C:14]3=[O:20])=[CH:9][CH:10]=2)[N:5]=[CH:4][N:3]=1Participants
3
Procedure
The title compound is prepared as described in EXAMPLE 123, using 1-(4-amino-quinazoline-7-ylmethyl)-3-methyl-piperazine-2-one, EXAMPLE 80, and 3-(4-chloro-thiophen-2-yl)-(E)-acrylic acid, EXAMPLE 26. 1H NMR (d6-DMSO, 300 MHz) δ9.74 (bs, 2H), 8.82 (s, 1H), 8.40 (d, 1H), 7.62 (m, 5H), 7.05 (d, 1H), 4.92 (m, 1H), 4.80 (m, 2H), 4.73 (m, 1H), 4.50 (m, 1H), 3.40 (m, 2H), 1.42 (m, 3H). ESI MS, [M+H]+=442, 444 (Cl pattern).
Sources & evidence
- ORD record
- ord-5aa224cbba16404fa0a3a0d901c2555d
- Source dataset
- uspto-grants-2009_11
- Patent number
- US07612075B2
Reaction notes
Loading…